Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks

British Journal of Dermatology

Volumn 164, Issue 6, 2011, Pages 1383-1386

  Gambichler, T ^a   Tigges, C ^a   Scola, N ^a   Weber, J ^a   Skrygan, M ^a   Bechara, F G ^a   Altmeyer, P ^a   Kreuter, A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; ETANERCEPT; T6 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MONOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; TREATMENT DURATION; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ADMINISTRATION, CUTANEOUS; ADULT; ANTIGENS, CD1; CELL DIFFERENTIATION; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULIN G; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 79957596433     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10358.x     Document Type: Article

References (15)

1. Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (Suppl. 2): 1-70.
2. Smith CH, Anstey AV, Barker JN, et al. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 2005; 153: 486-97. (Pubitemid 41248202)
3. Wolf P, Hofer A, Legat FJ, et al. Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept. Br J Dermatol 2009; 160: 186-9.
4. Kircik L, Bagel J, Korman N, et al.; Unite Study Group. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes. J Drugs Dermatol 2008; 7: 245-53.
5. De Simone C, D'Agostino M, Capponi A, et al. Combined treatment with etanercept and narrow band UVB phototherapy for chronic plaque psoriasis. 21st World Congress of Dermatology, Buenos Aires, Argentina, 2007.
6. Leonardi CL, Powers JL, Matheson RT, et al.; Etanercept Psoriasis Study Group. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003; 349: 2014-22. (Pubitemid 37448924)
7. Kienbaum S, Lehmann P, Ruzicka T,. Topical calcipotriol in the treatment of intertriginous psoriasis. Br J Dermatol 1996; 135: 647-50. (Pubitemid 26340286)
8. Gambichler T, Boms S, Hochdorfer B, et al. Immunohistology of amicrobial pustulosis of the folds. Clin Exp Dermatol 2007; 32: 155-8. (Pubitemid 46233018)
9. Boonstra A, Savelkoul HF,. The role of cytokines in ultraviolet-B induced immunosuppression. Eur Cytokine Netw 1997; 8: 117-23. (Pubitemid 28152137)
10. van Lingen RG, Körver JE, van de Kerkhof PC, et al. Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies. Br J Dermatol 2008; 159: 91-6. (Pubitemid 351874502)
11. Elias AN, Nanda VS, Barr RJ,. CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene. BMC Dermatol 2003; 3: 3.
12. Vissers WH, van Vlijmen I, van Erp PE, et al. Topical treatment of mild to moderate plaque psoriasis with 0·3% tacrolimus gel and 0·5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. Br J Dermatol 2008; 158: 705-12. (Pubitemid 351415744)
13. Weichenthal M, Schwarz T,. Phototherapy: how does UV work? Photodermatol Photoimmunol Photomed 2005; 21: 260-6. (Pubitemid 41387341)
14. Gambichler T, Tigges C, Dith A, et al. Impact of etanercept treatment on ultraviolet B induced inflammation, cell cycle regulation, and DNA damage. Br J Dermatol 2011; 164: 110-15.
15. Di Lernia V, Albertini G,. Is antitumour necrosis factor therapy combined with ultraviolet B phototherapy safe? Br J Dermatol 2010; 162: 1147-8.